Czechia· CZ-0245258
FLUCINAR
A fluocinolone acetonide product containing fluocinolone acetonide, registered in Czechia by Bausch Health Ireland Limited, Dublin. The same ATC class is registered in 7 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Fluocinolone acetonide is registered in 7 of 19 countries.
Countries holding a registration under ATC D07AC04 (fluocinolone acetonide), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 4 of them publish a price we can compare per daily dose
Fluocinolone acetonide · ATC D07AC04
7 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FLUOCINOLONE ACETONIDE
- Manufacturer
- Bausch Health Ireland Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- D07AC04
- ATC class
- Fluocinolone acetonide
- Defined daily dose
- 0.3 mg, T
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl024525815GCZK 107.16
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
10 interactions on record for fluocinolone acetonide.
Graded by severity as the source publishes them — 10 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluocinolone acetonide · interactions on record
10 records
Same medicine, other countries
Fluocinolone acetonide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandFlucinarDelfarma Sp. z o.o.
- United StatesFluocinolone AcetonideE. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
- United KingdomILUVIEN 190microgram intravitreal implant in applicatorAlimera Sciences Ltd
- NorwayIluvienAlimera
- FinlandIluvienAlimera Sciences Europe Limited
- GermanyFlucinarAbanta Pharma Gmbh
- Japanフルオシノロンアセトニド陽進堂ホールディングス
- CanadaDERMA SMOOTHE/FS LIQ 0.01%HILL DERMACEUTICALS INC
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Iluvien
- Belgium · Iluvien
- Bulgaria · Абрикорт, Флуцинар
- Germany · Flucinar, Iluvien
- Denmark · Iluvien, Otazem
- Spain · Ekzem, Fluocid Forte
- Finland · Iluvien, Otazem
- France · Iluvien
- United Kingdom (Northern Ireland) · Iluvien, Synalar
- Greece · Synalar Simple
- Hungary · Flucinar
- Ireland · Iluvien
- Italy · Ekzem, Fluovitef
- Lithuania · Flucinar
- Luxembourg · Iluvien
- Latvia · Flucinar
- Netherlands · Iluvien
- Norway · Iluvien, Otazem
- Poland · Flucinar, Iluvien
- Portugal · Ekzem, Iluvien
- Romania · Fluocinolon Acetonid Laropharm
- Sweden · Iluvien, Otazem
- Slovakia · Flucinar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20f966cc-59c3-4ffb-ae3d-c39f1da5c747 GET /v1/drugs/20f966cc-59c3-4ffb-ae3d-c39f1da5c747?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "UNG",
"source": "sukl",
"strength": "0,25MG/G",
"pack_size": "15G",
"substance": "FLUOCINOLONE ACETONIDE",
"cz_kod_sukl": "0245258",
"product_type": "CH",
"substance_codes": "635",
"registration_state": "R",
"registration_number": "46/063/74-S/C"
}See everything about fluocinolone acetonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.